Results 311 to 320 of about 349,023 (332)
Some of the next articles are maybe not open access.
2010
Vaccination against viral agents has considerably alleviated the burden associated with viral diseases and has saved millions of lives worldwide. Global vaccination eradicated diseases like polio and other vaccines have led to a significant decline in infection rates and related complications of viral diseases.
Brian Berman, Ivan Dario Camacho
openaire +2 more sources
Vaccination against viral agents has considerably alleviated the burden associated with viral diseases and has saved millions of lives worldwide. Global vaccination eradicated diseases like polio and other vaccines have led to a significant decline in infection rates and related complications of viral diseases.
Brian Berman, Ivan Dario Camacho
openaire +2 more sources
Viral vaccines for aquaculture
Annual Review of Fish Diseases, 1993Abstract A description of the types of viral vaccines that are being developed for fish is presented in this review. All three types of vaccines, i.e. killed, attenuated, and subunit vaccines, have worked to some extent in fish under controlled laboratory conditions.
John L. Fryer, J.C. Leong
openaire +2 more sources
Impact of glycosylation on viral vaccines
Carbohydrate PolymersGlycosylation is the most prominent modification important for vaccines and its specific pattern depends on several factors that need to be considered when developing a new biopharmaceutical. Tailor-made glycosylation can be exploited to develop more effective and safer vaccines; for this reason, a deep understanding of both glycoengineering strategies
Lembo A. +4 more
openaire +3 more sources
Vaccines to Prevent Viral Hepatitis
New England Journal of Medicine, 1997At least five different viruses cause hepatitis in humans. Two — hepatitis A virus (HAV) and hepatitis E virus (HEV) — are nonenveloped RNA viruses that are spread predominantly by fecal–oral transmission and cause acute self-limited disease.1,2 The others — hepatitis B virus (HBV), hepatitis delta virus (HDV), and hepatitis C virus (HCV) — are ...
Stanley M. Lemon, David L. Thomas
openaire +3 more sources
Viral Vaccines for Cancer Immunotherapy
Hematology/Oncology Clinics of North America, 2006The understanding that tumor cells can be recognized and eliminated by the immune system has led to intense interest in the development of cancer vaccines. Viruses are naturally occurring agents that cause human disease but have the potential to prevent disease when attenuated forms or subunits are used as vaccines before exposure.
Brian M. Elliott +2 more
openaire +3 more sources
Seminars in Oncology, 2005
Recent advances in understanding tumor-specific immunity have introduced new excitement in the clinical development of vaccines for the treatment of cancer. A better understanding of basic immunologic principles has led to a variety of techniques for enhancing tumor-specific immunity through vaccination.
Howard L. Kaufman +2 more
openaire +3 more sources
Recent advances in understanding tumor-specific immunity have introduced new excitement in the clinical development of vaccines for the treatment of cancer. A better understanding of basic immunologic principles has led to a variety of techniques for enhancing tumor-specific immunity through vaccination.
Howard L. Kaufman +2 more
openaire +3 more sources
The standardization of viral vaccines
New Zealand Veterinary Journal, 1960Abstract Extract The production of any new vaccine on a mass basis must necessarily be accompanied by a certain amount of risk that the product may not be entirely safe. The necessity for including adequate control tests for some specific factor associated with either safety or potency may not be foreseen initially and, as in the case of an early batch
openaire +2 more sources
2011
HAV and HBV are prevalent worldwide, cause significant morbidity and mortality, and are vaccine-preventable.
Stephen K. Tyring, Melissa L. Diamantis
openaire +2 more sources
HAV and HBV are prevalent worldwide, cause significant morbidity and mortality, and are vaccine-preventable.
Stephen K. Tyring, Melissa L. Diamantis
openaire +2 more sources
Vaccines for prevention of viral hepatitis
Haemophilia, 1998Summary. At the end of the 20th century active immunization against hepatitis A and B has been introduced into routine medical practice. Therefore, patients at risk, and especially those with coagulation disorders, should be immunized at the earliest age possible.
C. A. Lee +5 more
openaire +2 more sources
2004
Tumor-associated antigens (TAAs) are by definition either weakly immunogenic or functionally nonimmunogenic. Vaccine strategies must be developed in which the presentation of these TAAs to the immune system results in far greater activation of T cells than is being achieved naturally in the host.
Jeffrey Schlom +2 more
openaire +2 more sources
Tumor-associated antigens (TAAs) are by definition either weakly immunogenic or functionally nonimmunogenic. Vaccine strategies must be developed in which the presentation of these TAAs to the immune system results in far greater activation of T cells than is being achieved naturally in the host.
Jeffrey Schlom +2 more
openaire +2 more sources